<html><head><title>artl_s8.htm</title><!--Document Created by EDGARMaster--></head><body style="TEXT-ALIGN: left; FONT: 10pt TIMES NEW ROMAN; MARGIN: 0px 7%"><p style="MARGIN: 0px; text-align:center;"><strong>As filed with the Securities and Exchange Commission on June 25, 2020</strong></p><p style="MARGIN: 0px; text-align:right;"><strong>&nbsp;</strong></p><p style="MARGIN: 0px; text-align:right;"><strong>Registration No. 333-</strong> </p><table style="font-size:1px;width:100%" cellpadding="1"> <tr> <td style="border-bottom:2px solid;padding:1px;"></td></tr> <tr> <td style="border-bottom:5px solid;padding-bottom:1px;padding-top:1px;padding-left:1px;padding-right:1px;padding:1px;"></td></tr></table> <p style="margin:0px">&nbsp; </p><p style="MARGIN: 0px; text-align:center;"><strong>SECURITIES AND EXCHANGE COMMISSION</strong></p><p style="MARGIN: 0px; text-align:center;"><strong>Washington, D.C. 20549</strong></p><p style="MARGIN: 0px; text-align:center;">&nbsp; _____________________</p><p style="MARGIN: 0px; text-align:center;"><br><font style="font-size:18pt"><strong>FORM S&#8209;8</strong></font><br><strong>REGISTRATION STATEMENT</strong><em><br><strong>Under</strong></em><em><br><strong>The Securities Act of 1933</strong></em></p><p style="MARGIN: 0px; text-align:center;">_____________________ </p><p style="MARGIN: 0px; text-align:justify;">&nbsp; </p><table style="border-spacing:0;font-size:10pt;text-align:justify;margin-left:auto;margin-right:auto;width:50%;border-collapse:collapse;" cellpadding="0"> <tr style="height:15px"> <td style="BORDER-BOTTOM: 1px solid;"> <p style="MARGIN: 0px; text-align:center;"><font style="font-size:18pt"><strong>Artelo Biosciences, Inc.</strong></font></p></td></tr> <tr style="height:15px"> <td> <p style="MARGIN: 0px; text-align:center;">(Exact name of Registrant as specified in its charter)</p></td></tr></table> <p style="MARGIN: 0px; text-align:center;">_____________________</p><p style="MARGIN: 0px; text-align:justify;">&nbsp;</p><table style="border-spacing:0;font-size:10pt;text-align:justify;margin-left:auto;margin-right:auto;width:85%;border-collapse:collapse;" cellpadding="0"> <tr style="height:15px"> <td style="BORDER-BOTTOM: 1px solid;width:45%;vertical-align:top;"> <p style="MARGIN: 0px; text-align:center;"><strong>Nevada</strong></p></td> <td style="width:10%;"> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td style="BORDER-BOTTOM: 1px solid;width:45%;vertical-align:top;"> <p style="MARGIN: 0px; text-align:center;"><strong>33-1220924</strong></p></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:center;">(State or other jurisdiction of</p><p style="MARGIN: 0px; text-align:center;">incorporation or organization)</p></td> <td> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:center;">(I.R.S. Employer</p><p style="MARGIN: 0px; text-align:center;">Identification Number)</p></td></tr></table> <p style="MARGIN: 0px; text-align:center;"><br><strong>888 Prospect Street, Suite 210<br>La Jolla, CA 92037<br><u>(760) 943-1689</u></strong></p><p style="MARGIN: 0px; text-align:center;">(Address, including zip code, and telephone number, including area code, of Registrant&#8217;s principal executive offices)</p><p style="MARGIN: 0px; text-align:center;">_____________________</p><p style="MARGIN: 0px; text-align:justify;">&nbsp;</p><p style="MARGIN: 0px; text-align:center;"><strong>Artelo Biosciences, Inc. 2018 Equity Incentive Plan&nbsp;</strong></p><p style="MARGIN: 0px; text-align:center;">(Full title of the plan)&nbsp;</p><p style="MARGIN: 0px; text-align:center;">&nbsp;<br><strong>Gregory D. Gorgas<br>Chief Executive Officer and President<br>888 Prospect Street, Suite 210<br>La Jolla, CA 92037<br><u>Telephone: (760) 943-1689</u></strong></p><p style="MARGIN: 0px; text-align:center;">(Name, address, including zip code, and telephone number, including area code, of agent for service)</p><p style="MARGIN: 0px; text-align:center;">_____________________</p><p style="MARGIN: 0px; text-align:center;">&nbsp;</p><p style="MARGIN: 0px; text-align:center;"><em>Copies to:</em><br><strong>Martin J. Waters<br>Wilson Sonsini Goodrich &amp; Rosati, P.C.<br>12235 El Camino Real<br>San Diego, CA 92130<br>Telephone: (858) 350-2300<br>Facsimile: (858) 350-2399</strong></p><p style="MARGIN: 0px; text-align:justify;">&nbsp;</p><p style="MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of &#8220;large accelerated filer&#8221;, &#8220;accelerated filer&#8221;, &#8220;smaller reporting company&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act. (Check one):</p><p style="MARGIN: 0px; text-align:justify;">&nbsp;</p><table style="border-spacing:0;font-size:10pt;text-align:justify;margin-left:auto;margin-right:auto;width:85%;border-collapse:collapse;" cellpadding="0"> <tr style="height:15px"> <td style="width:30%;"> <p style="MARGIN: 0px; text-align:justify;">Large accelerated filer</p></td> <td style="width:20%;"> <p style="MARGIN: 0px; text-align:justify;">&#9744;</p></td> <td style="width:30%;"> <p style="MARGIN: 0px; text-align:justify;">Accelerated filer</p></td> <td style="width:20%;"> <p style="MARGIN: 0px; text-align:justify;">&#9744;</p></td></tr> <tr style="height:15px"> <td> <p style="MARGIN: 0px; text-align:justify;">Non-accelerated filer </p></td> <td> <p style="MARGIN: 0px; text-align:justify;">&#9746;</p></td> <td> <p style="MARGIN: 0px; text-align:justify;">Smaller reporting company </p></td> <td> <p style="MARGIN: 0px; text-align:justify;">&#9746;</p></td></tr> <tr style="height:15px"> <td></td> <td> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td> <p style="MARGIN: 0px; text-align:justify;">Emerging growth company</p></td> <td> <p style="MARGIN: 0px; text-align:justify;">&#9746;</p></td></tr></table> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p><p style="MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided to Section 7(a)(2)(B) of the Securities Act. &#9744;</p><p style="MARGIN: 0px; text-align:justify;">&nbsp;</p><table style="font-size:1px;width:100%" cellpadding="1"> <tr> <td style="border-bottom:2px solid;padding:1px;"></td></tr> <tr> <td style="border-bottom:5px solid;padding-bottom:1px;padding-top:1px;padding-left:1px;padding-right:1px;padding:1px;"></td></tr></table> <table style="border-spacing:0;font:10pt times new roman;width:100%;border-collapse:collapse;" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="TEXT-INDENT: 0px;"></td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="MARGIN: 0px; text-align:left;">&nbsp;</p><p style="MARGIN: 0px; text-align:center;"><strong>CALCULATION OF REGISTRATION FEE </strong></p><p style="MARGIN: 0px; text-align:justify;">&nbsp;</p><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%;border-collapse:collapse;" cellpadding="0"> <tr style="height:15px"> <td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"> <p style="MARGIN: 0px; text-align:left;"><br><strong>Title of Each Class of Securities to be Registered</strong></p></td> <td style="white-space: nowrap;"> <p style="margin:0px">&nbsp;</p></td> <td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"> <p style="MARGIN: 0px; text-align:center;"><strong>Amount</strong></p><p style="MARGIN: 0px; text-align:center;"><strong>to be</strong></p><p style="MARGIN: 0px; text-align:center;"><strong>Registered(1) </strong></p></td> <td style="PADDING-BOTTOM: 1px;white-space: nowrap;"> <p style="margin:0px">&nbsp;</p></td> <td style="white-space: nowrap;"> <p style="margin:0px">&nbsp;</p></td> <td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"> <p style="MARGIN: 0px; text-align:center;"><strong>Proposed</strong></p><p style="MARGIN: 0px; text-align:center;"><strong>Maximum</strong></p><p style="MARGIN: 0px; text-align:center;"><strong>Offering </strong></p><p style="MARGIN: 0px; text-align:center;"><strong>Price</strong></p><p style="MARGIN: 0px; text-align:center;"><strong>Per Share(2) </strong></p></td> <td style="PADDING-BOTTOM: 1px;white-space: nowrap;"> <p style="margin:0px">&nbsp;</p></td> <td style="white-space: nowrap;"> <p style="margin:0px">&nbsp;</p></td> <td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"> <p style="MARGIN: 0px; text-align:center;"><br><strong>Proposed</strong></p><p style="MARGIN: 0px; text-align:center;"><strong>Maximum</strong></p><p style="MARGIN: 0px; text-align:center;"><strong>Aggregate</strong></p><p style="MARGIN: 0px; text-align:center;"><strong>Offering </strong></p><p style="MARGIN: 0px; text-align:center;"><strong>Price </strong></p></td> <td style="PADDING-BOTTOM: 1px;white-space: nowrap;"> <p style="margin:0px">&nbsp;</p></td> <td style="white-space: nowrap;"> <p style="margin:0px">&nbsp;</p></td> <td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"> <p style="MARGIN: 0px; text-align:center;"><br><strong>Amount of</strong></p><p style="MARGIN: 0px; text-align:center;"><strong>Registration </strong></p><p style="MARGIN: 0px; text-align:center;"><strong>Fee</strong></p></td> <td style="PADDING-BOTTOM: 1px;white-space: nowrap;"> <p style="margin:0px">&nbsp;</p></td></tr> <tr style="height:15px;background-color:#cceeff"> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">Common Stock, $0.001 par value per share, reserved for issuance pursuant to the Artelo Biosciences, Inc. 2018 Equity Incentive Plan, as amended</p></td> <td style="width:1%;white-space: nowrap;"> <p style="margin:0px">&nbsp;</p></td> <td style="width:1%;white-space: nowrap;"> <p style="margin:0px">&nbsp;</p></td> <td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">425,000 </td> <td style="width:1%;vertical-align:bottom;white-space: nowrap;">(2)</td> <td style="width:1%;white-space: nowrap;"> <p style="margin:0px">&nbsp;</p></td> <td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td> <td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.44</td> <td style="width:1%;white-space: nowrap;"> <p style="margin:0px">&nbsp;</p></td> <td style="width:1%;white-space: nowrap;"> <p style="margin:0px">&nbsp;</p></td> <td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td> <td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">612,000.00</td> <td style="width:1%;white-space: nowrap;"> <p style="margin:0px">&nbsp;</p></td> <td style="width:1%;white-space: nowrap;"> <p style="margin:0px">&nbsp;</p></td> <td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td> <td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">79.44</td> <td style="width:1%;white-space: nowrap;"> <p style="margin:0px">&nbsp;</p></td></tr> <tr style="height:15px;background-color:#ffffff"> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">Total Registration Fee</p></td> <td style="width:1%;white-space: nowrap;"> <p style="margin:0px">&nbsp;</p></td> <td style="width:1%;white-space: nowrap;"> <p style="margin:0px">&nbsp;</p></td> <td class="ffcell" style="width:9%;"> <p style="margin:0px">&nbsp;</p></td> <td style="width:1%;white-space: nowrap;"> <p style="margin:0px">&nbsp;</p></td> <td style="width:1%;white-space: nowrap;"> <p style="margin:0px">&nbsp;</p></td> <td style="width:1%;white-space: nowrap;"> <p style="margin:0px">&nbsp;</p></td> <td class="ffcell" style="width:9%;"> <p style="margin:0px">&nbsp;</p></td> <td style="width:1%;white-space: nowrap;"> <p style="margin:0px">&nbsp;</p></td> <td style="width:1%;white-space: nowrap;"> <p style="margin:0px">&nbsp;</p></td> <td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td> <td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">612,000.00</td> <td style="width:1%;white-space: nowrap;"> <p style="margin:0px">&nbsp;</p></td> <td style="width:1%;white-space: nowrap;"> <p style="margin:0px">&nbsp;</p></td> <td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td> <td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">79.44</td> <td style="width:1%;white-space: nowrap;"> <p style="margin:0px">&nbsp;</p></td></tr></table> <p style="MARGIN: 0px; text-align:justify;">___________ </p><table style="border-spacing:0;font-size:10pt;width:100%;border-collapse:collapse;" cellpadding="0"> <tr style="height:15px"> <td style="width:3%;vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">(1)</p></td> <td style="vertical-align:top;"> <p style="margin:0px">Pursuant to Rule 416(a) of the Securities Act of 1933 (the &#8220;Securities Act&#8221;), as amended, this Registration Statement shall also cover any additional shares of the Registrant&#8217;s common stock that become issuable under the Artelo Biosciences, Inc. 2018 Equity Incentive Plan, as amended (&#8220;2018 Plan&#8221;) by reason of any stock dividend, stock split, recapitalization or other similar transaction effected without receipt of consideration that increases the number of the Registrant&#8217;s outstanding shares of common stock. </p></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="margin:0px">(2) </p></td> <td> <p style="margin:0px">Estimated solely for purposes of calculating the registration fee on the basis of $1.44 per share, in accordance with Rule 457(c) and (h) of the Securities Act, based upon the average of the high and low prices of the Registrant&#8217;s common stock as reported on The Nasdaq Stock market LLC on June 18, 2020.</p></td></tr></table> <p style="MARGIN: 0px; text-align:justify;">&nbsp;&nbsp; </p><table style="border-spacing:0;font:10pt times new roman;width:100%;border-collapse:collapse;" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">2</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="MARGIN: 0px; text-align:center;"><strong>&nbsp;<br>PART I</strong></p><p style="MARGIN: 0px; text-align:center;"><strong>&nbsp;<br>INFORMATION REQUIRED IN THE PROSPECTUS</strong></p><p style="MARGIN: 0px; text-align:justify;">&nbsp;</p><p style="MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">This Registration Statement on Form S-8 (the &#8220;Registration Statement&#8221;) registers 425,000 additional shares of the common stock of Artelo Biosciences, Inc. (the &#8220;Registrant&#8221;) that may be issued pursuant to the Registrant&#8217;s 2018 Equity Incentive Plan, as amended and restated (the &#8220;2018 Plan&#8221;). </p><p style="MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">&nbsp;</p><p style="MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">In accordance with General Instruction E to Form S-8, the contents of the previous Registration Statement on Form S-8 filed by the Registrant with the Securities and Exchange Commission (the &#8220;Commission&#8221;) on January 15, 2020 (File No. 333-235916) (the &#8220;Previous Form S-8&#8221;) is incorporated by reference into this Registration Statement.</p><p style="MARGIN: 0px; text-align:center;">&nbsp;<br><strong>PART II&nbsp;</strong></p><p style="MARGIN: 0px; text-align:center;"><br><strong>INFORMATION REQUIRED IN REGISTRATION STATEMENT</strong></p><p style="MARGIN: 0px; text-align:justify;">&nbsp;<br><strong>Item 3. Incorporation of Documents by Reference.</strong> </p><p style="MARGIN: 0px; text-align:justify;">&nbsp;</p><p style="MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">Artelo Biosciences, Inc. (the &#8220;<strong>Registrant</strong>&#8221; or &#8220;<strong>Artelo</strong>&#8221;) hereby incorporates by reference into this Registration Statement the following documents previously filed with the Securities and Exchange Commission (the &#8220;<strong>Commission</strong>&#8221;):</p><p style="MARGIN: 0px; text-align:justify;">&nbsp; </p><table style="border-spacing:0;font-size:10pt;font-variant:normal;font-weight:normal;font-style:normal;text-align:left;line-height:normal;width:100%;border-collapse:collapse;" cellpadding="0"> <tr style="height:15px"> <td> <p style="margin:0px">&nbsp;</p></td> <td> <p style="margin:0px"><font style="font-family:symbol">&#183;</font></p></td> <td> <p style="margin:0px">Artelo&#8217;s Annual Report on Form 10-K for the fiscal year ended August 31, 2019 filed on November 25, 2019;</p></td></tr> <tr style="height:15px"> <td> <p style="margin:0px">&nbsp;</p></td> <td> <p style="margin:0px">&nbsp;</p></td> <td> <p style="margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="width:4%;"> <p style="margin:0px">&nbsp;</p></td> <td style="width:4%;vertical-align:top;"> <p style="margin:0px"><font style="font-family:symbol">&#183;</font></p></td> <td style="vertical-align:top;">Artelo&#8217;s Amended Annual Report on Form 10-K/A for the fiscal year ended August 31, 2019 filed on December 18, 2019;</td></tr> <tr style="height:15px"> <td> <p style="margin:0px">&nbsp;</p></td> <td> <p style="margin:0px;text-indent:30px">&nbsp;</p></td> <td> <p style="margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="margin:0px"><font style="font-family:symbol">&#183;</font></p></td> <td style="vertical-align:top;">&nbsp;Artelo&#8217;s Quarterly Reports on Form 10-Q for the quarter ended November 30, 2019, filed on January 14, 2020 and for the quarter ended February 29, 2020 filed on April 13, 2020;</td></tr> <tr style="height:15px"> <td> <p style="margin:0px">&nbsp;</p></td> <td> <p style="margin:0px;text-indent:30px">&nbsp;</p></td> <td> <p style="margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="margin:0px"><font style="font-family:symbol">&#183;</font></p></td> <td style="vertical-align:top;"> <p style="margin:0px">Artelo&#8217;s Current Reports on Form 8-K filed on September 6, 2019, December 6, 2019, February 7, 2020, March 11, 2020, April 15, 2020, and June 22, 2020; and</p></td></tr> <tr style="height:15px"> <td> <p style="margin:0px">&nbsp;</p></td> <td> <p style="margin:0px;text-indent:30px">&nbsp;</p></td> <td> <p style="margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="margin:0px"><font style="font-family:symbol">&#183;</font></p></td> <td style="vertical-align:top;">Artelo&#8217;s description of its common stock set forth in the registration statement on Form 8-A registering the common stock under Section 12 of the Exchange Act filed on June 21, 2019, including any amendments or reports filed for purposes of updating such description.</td></tr></table> <p style="margin:0px">&nbsp;</p><p style="MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">All documents filed by the Registrant pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act on or after the date of this Registration Statement and prior to the filing of a post-effective amendment to this Registration Statement that indicates that all securities offered have been sold or that deregisters all securities then remaining unsold shall be deemed to be incorporated by reference in this Registration Statement and to be part hereof from the date of filing of such documents; <em>provided</em>, <em>however</em>, that documents or information deemed to have been furnished and not filed in accordance with the rules of the Commission shall not be deemed incorporated by reference into this Registration Statement. Any statement contained in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained herein or in any subsequently filed document which also is deemed to be incorporated by reference herein modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.</p><p style="MARGIN: 0px; text-align:justify;">&nbsp;</p><table style="border-spacing:0;font:10pt times new roman;width:100%;border-collapse:collapse;" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">3</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="margin:0px"><strong>&nbsp;<br>Item 8. Exhibits. </strong></p><p style="MARGIN: 0px; text-align:justify;">&nbsp;</p><table style="border-spacing:0;font-size:10pt;width:100%;border-collapse:collapse;" cellpadding="0"> <tr style="height:15px"> <td style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;"> <p style="MARGIN: 0px; text-align:justify;"><strong>Exhibit Number</strong></p></td> <td style="width:2%;"></td> <td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"> <p style="MARGIN: 0px; text-align:justify;"><strong>Description</strong></p></td></tr> <tr style="height:15px;background-color:#cceeff"> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;"><a href="http://www.sec.gov/Archives/edgar/data/1621221/000164033420000082/artl_ex41.htm">4.1</a></p></td> <td></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;"><a href="http://www.sec.gov/Archives/edgar/data/1621221/000164033420000082/artl_ex41.htm">Specimen Common Stock Certificate of the Registrant (which is incorporated herein by reference to Exhibit 4.1 to the Registrant&#8217;s previous Registration Statement on Form S-8 (Registration No. 333-235916). </a></p></td></tr> <tr style="height:15px;background-color:#ffffff"> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;"><a href="artl_ex51.htm">5.1</a></p></td> <td></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;"><a href="artl_ex51.htm">Opinion of Fennemore Craig, P.C.</a></p></td></tr> <tr style="height:15px;background-color:#cceeff"> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;"><a href="artl_ex231.htm">23.1</a></p></td> <td></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;"><a href="artl_ex231.htm">Consent of MaloneBailey, LLP, Independent Registered Public Accounting Firm.</a></p></td></tr> <tr style="height:15px;background-color:#ffffff"> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;"><a href="artl_ex51.htm">23.2</a></p></td> <td></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;"><a href="artl_ex51.htm">Consent of Fennemore Craig, P.C. (contained in Exhibit 5.1 hereto).</a></p></td></tr> <tr style="height:15px;background-color:#cceeff"> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;"><a href="#poa">24.1</a></p></td> <td></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;"><a href="#poa">Power of Attorney (contained on signature page hereto).</a></p></td></tr> <tr style="height:15px;background-color:#ffffff"> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;"><a href="artl_ex991.htm">99.1+</a></p></td> <td> <p style="margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;"><a href="artl_ex991.htm">Artelo Biosciences, Inc. 2018 Equity Incentive Plan, as amended.</a></p></td></tr></table> <p style="MARGIN: 0px; text-align:justify;">&nbsp; </p><p style="MARGIN: 0px; text-align:justify;">+ Indicates management contract or compensatory plan, contract or arrangement.</p><p style="MARGIN: 0px; text-align:justify;">&nbsp;</p><table style="border-spacing:0;font:10pt times new roman;width:100%;border-collapse:collapse;" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">4</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="MARGIN: 0px; text-align:center;"><br><strong>SIGNATURES</strong></p><p style="MARGIN: 0px; text-align:justify;">&nbsp;</p><p style="MARGIN: 0px; text-align:justify;">Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of San Diego, State of California, on June 25, 2020.</p><p style="MARGIN: 0px; text-align:justify;">&nbsp;</p><table style="border-spacing:0;font-size:10pt;width:100%;border-collapse:collapse;" cellpadding="0"> <tr style="height:15px"> <td> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td colspan="2"> <p style="MARGIN: 0px; text-align:justify;"><strong>ARTELO BIOSCIENCES, INC.</strong></p></td> <td></td></tr> <tr style="height:15px"> <td style="width:50%;"></td> <td style="width:5%;"></td> <td style="width:35%;"></td> <td style="width:10%;"></td></tr> <tr style="height:15px"> <td> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td> <p style="MARGIN: 0px; text-align:justify;">By:</p></td> <td style="BORDER-BOTTOM: 1px solid;"> <p style="MARGIN: 0px; text-align:justify;">/s/ Gregory D. Gorgas</p></td> <td></td></tr> <tr style="height:15px"> <td> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td> <p style="MARGIN: 0px; text-align:justify;">Name:</p></td> <td> <p style="MARGIN: 0px; text-align:justify;">Gregory D. Gorgas</p></td> <td></td></tr> <tr style="height:15px"> <td> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td> <p style="MARGIN: 0px; text-align:justify;">Title:</p></td> <td> <p style="MARGIN: 0px; text-align:justify;">President &amp; Chief Executive Officer</p></td> <td></td></tr></table> <p style="MARGIN: 0px; text-align:left;">&nbsp;</p><p style="MARGIN: 0px; text-align:center;"><strong><a name="poa">Power of Attorney</a></strong></p><p style="MARGIN: 0px; text-align:center;">&nbsp;</p><p style="MARGIN: 0px; text-align:justify;">KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below hereby constitutes and appoints Gregory D. Gorgas, as his or her true and lawful attorney-in-fact and agent, with full power of substitution and re-substitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments), to this Registration Statement on Form S-8 with all exhibits thereto and all documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorney-in-fact and agent, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully for all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent, or his substitutes, may lawfully do or cause to be done by virtue hereof.</p><p style="MARGIN: 0px; text-align:justify;">&nbsp;</p><p style="MARGIN: 0px; text-align:justify;">Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the dates indicated:</p><p style="MARGIN: 0px; text-align:justify;">&nbsp;</p><table style="border-spacing:0;font-size:10pt;width:100%;border-collapse:collapse;" cellpadding="0"> <tr style="height:15px"> <td style="BORDER-BOTTOM: 1px solid;width:35%;vertical-align:bottom;"> <p style="MARGIN: 0px; text-align:center;"><strong>Name</strong></p></td> <td style="width:2%;"> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"> <p style="MARGIN: 0px; text-align:center;"><strong>Title</strong></p></td> <td style="width:2%;"> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td style="BORDER-BOTTOM: 1px solid;width:20%;vertical-align:top;"> <p style="MARGIN: 0px; text-align:center;"><strong>Date</strong></p></td></tr> <tr style="height:15px"> <td></td> <td></td> <td></td> <td></td> <td> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"> <p style="MARGIN: 0px; text-align:justify;">/s/ Gregory D. Gorgas</p></td> <td> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">President, Chief Executive Officer and Director</p></td> <td> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">June 25, 2020</p></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">Gregory D. Gorgas</p></td> <td> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td> <p style="MARGIN: 0px; text-align:justify;">(Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer)</p></td> <td></td> <td></td></tr> <tr style="height:15px"> <td></td> <td></td> <td></td> <td></td> <td> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: 1px solid;"> <p style="MARGIN: 0px; text-align:justify;">/s/ Connie Matsui</p></td> <td> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td> <p style="MARGIN: 0px; text-align:justify;">Director, Chair of the Board</p></td> <td> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">June 25, 2020</p></td></tr> <tr style="height:15px"> <td> <p style="MARGIN: 0px; text-align:justify;">Connie Matsui</p></td> <td></td> <td></td> <td></td> <td></td></tr> <tr style="height:15px"> <td></td> <td></td> <td></td> <td></td> <td> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: 1px solid;vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">/s/ Steven Kelly</p></td> <td> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">Director</p></td> <td> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">June 25, 2020</p></td></tr> <tr style="height:15px"> <td> <p style="MARGIN: 0px; text-align:justify;">Steven Kelly</p></td> <td></td> <td></td> <td></td> <td></td></tr> <tr style="height:15px"> <td></td> <td></td> <td></td> <td></td> <td> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: 1px solid;vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">/s/ Douglas Blayney</p></td> <td> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">Director</p></td> <td> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">June 25, 2020</p></td></tr> <tr style="height:15px"> <td> <p style="MARGIN: 0px; text-align:justify;">Douglas Blayney</p></td> <td></td> <td></td> <td></td> <td></td></tr> <tr style="height:15px"> <td></td> <td></td> <td></td> <td></td> <td> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: 1px solid;vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">/s/ R. Martin Emanuele</p></td> <td> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">Director</p></td> <td> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">June 25, 2020</p></td></tr> <tr style="height:15px"> <td> <p style="MARGIN: 0px; text-align:justify;">R. Martin Emanuele</p></td> <td></td> <td></td> <td></td> <td></td></tr> <tr style="height:15px"> <td></td> <td></td> <td></td> <td></td> <td> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: 1px solid;vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">/s/ John W. Beck</p></td> <td> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">Director</p></td> <td> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">June 25, 2020</p></td></tr> <tr style="height:15px"> <td> <p style="MARGIN: 0px; text-align:justify;">John W. Beck</p></td> <td></td> <td></td> <td></td> <td></td></tr></table> <p style="MARGIN: 0px 0px 0px 0.35pt; text-align:justify;">&nbsp;</p><p style="MARGIN: 0px 0px 0px 0.35pt; text-align:justify;">&nbsp;</p><table style="border-spacing:0;font:10pt times new roman;width:100%;border-collapse:collapse;" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;"> <p style="MARGIN: 0px; text-align:center;">5</p></td></tr></table> <p style="margin:0px">&nbsp; </p><body>
[{"type": "S-8", "sequence": "1", "filename": "artl_s8.htm", "description": "FORM S-8", "secsgml_size_bytes": 34766}]
{"company-data": {"conformed-name": "ARTELO BIOSCIENCES, INC.", "cik": "0001621221", "assigned-sic": "7389", "irs-number": "331220924", "state-of-incorporation": "NV", "fiscal-year-end": "0831"}, "filing-values": {"form-type": "S-8", "act": "33", "file-number": "333-239434", "film-number": "20989820"}, "business-address": {"street1": "888 PROSPECT STREET, SUITE 210", "city": "LA JOLLA", "state": "CA", "zip": "92037", "phone": "760-943-1689"}, "mail-address": {"street1": "888 PROSPECT STREET, SUITE 210", "city": "LA JOLLA", "state": "CA", "zip": "92037"}, "former-company": [{"former-conformed-name": "REACTIVE MEDICAL INC.", "date-changed": "20170207"}, {"former-conformed-name": "KNIGHT KNOX DEVELOPMENT CORP.", "date-changed": "20141001"}]}
artl_s8.htm
As filed with the Securities and Exchange Commission on June 25, 2020
Registration No. 333-
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_____________________
FORM S‑8
REGISTRATION STATEMENT
Under
The Securities Act of 1933
_____________________
Artelo Biosciences, Inc.
(Exact name of Registrant as specified in its charter)
_____________________
Nevada
33-1220924
(State or other jurisdiction of
incorporation or organization)
(I.R.S. Employer
Identification Number)
888 Prospect Street, Suite 210
La Jolla, CA 92037
(760) 943-1689
(Address, including zip code, and telephone number, including area code, of Registrant's principal executive offices)
_____________________
Artelo Biosciences, Inc. 2018 Equity Incentive Plan
(Full title of the plan)
Gregory D. Gorgas
Chief Executive Officer and President
888 Prospect Street, Suite 210
La Jolla, CA 92037
Telephone: (760) 943-1689
(Name, address, including zip code, and telephone number, including area code, of agent for service)
_____________________
Copies to:
Martin J. Waters
Wilson Sonsini Goodrich & Rosati, P.C.
12235 El Camino Real
San Diego, CA 92130
Telephone: (858) 350-2300
Facsimile: (858) 350-2399
Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of "large accelerated filer", "accelerated filer", "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated filer
☐
Accelerated filer
☐
Non-accelerated filer
☒
Smaller reporting company
☒
Emerging growth company
☒
If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided to Section 7(a)(2)(B) of the Securities Act. ☐
CALCULATION OF REGISTRATION FEE
Title of Each Class of Securities to be Registered
Amount
to be
Registered(1)
Proposed
Maximum
Offering
Price
Per Share(2)
Proposed
Maximum
Aggregate
Offering
Price
Amount of
Registration
Fee
Common Stock, $0.001 par value per share, reserved for issuance pursuant to the Artelo Biosciences, Inc. 2018 Equity Incentive Plan, as amended
425,000
(2)
$
1.44
$
612,000.00
$
79.44
Total Registration Fee
$
612,000.00
$
79.44
___________
(1)
Pursuant to Rule 416(a) of the Securities Act of 1933 (the "Securities Act"), as amended, this Registration Statement shall also cover any additional shares of the Registrant's common stock that become issuable under the Artelo Biosciences, Inc. 2018 Equity Incentive Plan, as amended ("2018 Plan") by reason of any stock dividend, stock split, recapitalization or other similar transaction effected without receipt of consideration that increases the number of the Registrant's outstanding shares of common stock.
(2)
Estimated solely for purposes of calculating the registration fee on the basis of $1.44 per share, in accordance with Rule 457(c) and (h) of the Securities Act, based upon the average of the high and low prices of the Registrant's common stock as reported on The Nasdaq Stock market LLC on June 18, 2020.
2
PART I
INFORMATION REQUIRED IN THE PROSPECTUS
This Registration Statement on Form S-8 (the "Registration Statement") registers 425,000 additional shares of the common stock of Artelo Biosciences, Inc. (the "Registrant") that may be issued pursuant to the Registrant's 2018 Equity Incentive Plan, as amended and restated (the "2018 Plan").
In accordance with General Instruction E to Form S-8, the contents of the previous Registration Statement on Form S-8 filed by the Registrant with the Securities and Exchange Commission (the "Commission") on January 15, 2020 (File No. 333-235916) (the "Previous Form S-8") is incorporated by reference into this Registration Statement.
PART II
INFORMATION REQUIRED IN REGISTRATION STATEMENT
Item 3. Incorporation of Documents by Reference.
Artelo Biosciences, Inc. (the "
Registrant
" or "
Artelo
") hereby incorporates by reference into this Registration Statement the following documents previously filed with the Securities and Exchange Commission (the "
Commission
"):
·
Artelo's Annual Report on Form 10-K for the fiscal year ended August 31, 2019 filed on November 25, 2019;
·
Artelo's Amended Annual Report on Form 10-K/A for the fiscal year ended August 31, 2019 filed on December 18, 2019;
·
Artelo's Quarterly Reports on Form 10-Q for the quarter ended November 30, 2019, filed on January 14, 2020 and for the quarter ended February 29, 2020 filed on April 13, 2020;
·
Artelo's Current Reports on Form 8-K filed on September 6, 2019, December 6, 2019, February 7, 2020, March 11, 2020, April 15, 2020, and June 22, 2020; and
·
Artelo's description of its common stock set forth in the registration statement on Form 8-A registering the common stock under Section 12 of the Exchange Act filed on June 21, 2019, including any amendments or reports filed for purposes of updating such description.
All documents filed by the Registrant pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act on or after the date of this Registration Statement and prior to the filing of a post-effective amendment to this Registration Statement that indicates that all securities offered have been sold or that deregisters all securities then remaining unsold shall be deemed to be incorporated by reference in this Registration Statement and to be part hereof from the date of filing of such documents;
provided
,
however
, that documents or information deemed to have been furnished and not filed in accordance with the rules of the Commission shall not be deemed incorporated by reference into this Registration Statement. Any statement contained in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained herein or in any subsequently filed document which also is deemed to be incorporated by reference herein modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.
3
Item 8. Exhibits.
Exhibit Number
Description
4.1
Specimen Common Stock Certificate of the Registrant (which is incorporated herein by reference to Exhibit 4.1 to the Registrant's previous Registration Statement on Form S-8 (Registration No. 333-235916).
5.1
Opinion of Fennemore Craig, P.C.
23.1
Consent of MaloneBailey, LLP, Independent Registered Public Accounting Firm.
23.2
Consent of Fennemore Craig, P.C. (contained in Exhibit 5.1 hereto).
24.1
Power of Attorney (contained on signature page hereto).
99.1+
Artelo Biosciences, Inc. 2018 Equity Incentive Plan, as amended.
+ Indicates management contract or compensatory plan, contract or arrangement.
4
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of San Diego, State of California, on June 25, 2020.
ARTELO BIOSCIENCES, INC.
By:
/s/ Gregory D. Gorgas
Name:
Gregory D. Gorgas
Title:
President & Chief Executive Officer
Power of Attorney
KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below hereby constitutes and appoints Gregory D. Gorgas, as his or her true and lawful attorney-in-fact and agent, with full power of substitution and re-substitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments), to this Registration Statement on Form S-8 with all exhibits thereto and all documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorney-in-fact and agent, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully for all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent, or his substitutes, may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the dates indicated:
Name
Title
Date
/s/ Gregory D. Gorgas
President, Chief Executive Officer and Director
June 25, 2020
Gregory D. Gorgas
(Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer)
/s/ Connie Matsui
Director, Chair of the Board
June 25, 2020
Connie Matsui
/s/ Steven Kelly
Director
June 25, 2020
Steven Kelly
/s/ Douglas Blayney
Director
June 25, 2020
Douglas Blayney
/s/ R. Martin Emanuele
Director
June 25, 2020
R. Martin Emanuele
/s/ John W. Beck
Director
June 25, 2020
John W. Beck
5